U.S. Approves First Self-Administered Nasal Flu Vaccine
The U.S. FDA has approved AstraZeneca’s FluMist nasal spray as the first self-administered flu vaccine, offering a needle-free option to boost vaccination rates and improve accessibility.
News & Insights Across Asia
The U.S. FDA has approved AstraZeneca’s FluMist nasal spray as the first self-administered flu vaccine, offering a needle-free option to boost vaccination rates and improve accessibility.
Apple’s AirPods Pro 2 have been approved by the FDA to function as hearing aids, offering an affordable and accessible option for individuals with hearing loss through a new personalized hearing feature.